Becton, Dickinson and Company has received $2.11 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 11 Financial Advisor in the Stock Trading Firms. Among 11 Analysts, Bottom line EPS Estimate for the current quarter is $2.06 while the top line estimate is $2.16 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at 7.47%.
Becton, Dickinson and Company reported better than expected with a surprise EPS of 1.44% or $0.03 during its most recent quarterly earnings. The Actual EPS was $2.12 compared to the Estimated EPS of $2.09. Franklin Lakes based Becton, Dickinson and Company Last reported the Quarter results on Dec 31, 2016 and the Next earnings date is scheduled to be released on Feb 02, 2017.
Becton, Dickinson and Company has a Price to Earnings ratio of 20.3 for the trailing twelve month period. The price to book ratio of the company for the most recent quarter is 4.88. For the Most Recent Fiscal Year, Becton, Dickinson and Company has a price to cash ratio of 12.48. For the Trailing twelve month period, company showed a Net Profit Margin of 7.82% and Return on Equity of the stock is 24.45%.
In the last quarter, Becton, Dickinson and Company reported Annual Earnings of $2.12. Based on the filings, last years Annual Earnings was, $8.59. In the last Quarter, BDX reported a surprise Earnings per Share of 1.44% . The consensus estimate for current quarter is $2.11 and for the current fiscal year, the estimate is $9.44. For the Next fiscal year, the estimate is $10.44 based on the consensus.
Becton, Dickinson and Company (NYSE:BDX) : On Tuesday heightened volatility was witnessed in Becton, Dickinson and Company (NYSE:BDX) which led to swings in the share price. The stock opened for trading at $174.41 and hit $177.54 on the upside , eventually ending the session at $177.29, with a gain of 1.41% or 2.47 points. The heightened volatility saw the trading volume jump to 1,545,738 shares. The 52-week high of the share price is $181.755 and the company has a market cap of $40,995 million. The 52-week low of the share price is at $129.5 .
Becton, Dickinson and Co. is engaged principally in the manufacture and sale of a broad line of supplies, devices and systems used by health care professionals, medical research institutions and the general public. BDs operations consist of three worldwide business segments: Medical Systems, Biosciences, and Preanalytical Solutions.